This study identifies CD73 (NT5E) as a direct hypoxia-responsive effector of HIF1α and demonstrates that dual inhibition of HIF1α and CD73 synergistically suppresses tumor cell viability, disrupts adenosine metabolism, and impairs angiogenic and migratory signaling. Here, HIF1A is linked to neoplasm.